Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes.

Previous work has demonstrated that inducible NO synthase (iNOS) can be expressed in cardiac myocytes. In this study, we investigated transcriptional regulation of the iNOS gene in these cells. Lipopolysaccharide (LPS) induced iNOS mRNA and protein in cultured neonatal rat cardiac myocytes. H-89, dexamethasone, herbimycin, genistein, staurosporine, or pyrrolidine dithiocarbamate (PDTC) attenuated the iNOS induction by LPS. Forskolin, interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, or interferon (IFN)-gamma enhanced the LPS-induced iNOS expression. Combined stimulation of IL-6 and TNF-alpha also induced iNOS. The 5'-upstream sequence of the rat iNOS gene contains the nuclear factor-kappa B (NF-kappa B) site, CAAT box, IFN-gamma activation site (GAS), and IFN regulatory factor (IRF) site. DNase I footprinting assay revealed that the nuclear factors binding to these elements were increased by LPS exposure. Transient transfection assay suggested that these elements were indispensable for transcriptional regulation of the iNOS induction. Electrophoretic mobility shift assay revealed that LPS or TNF-alpha increased binding activity for the NF-kappa B site. A slower-migrating complex binding to the CAAT box gave rise after exposure to LPS or forskolin. Competition assay suggested that this slower-migrating complex consisted of a heterodimer between a member of CAAT box/enhancer binding (C/EBP) protein family and cAMP responsive element binding protein (CREB). LPS or IL-6 increased binding complexes for the IRF site, which was compatible with induction of IRF-1. LPS, IL-6, or IFN-gamma induced a novel binding complex for GAS, which also existed in the 5'-flanking region of the IRF-1 gene. These data suggest that (1) iNOS induction simultaneously requires both NF-kappa B activation and IRF-1 induction, and (2) the heterodimer between C/EBP and CREB has synergistic effects on the iNOS induction via the CAAT box.

[1]  T. Taniguchi,et al.  Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated , 1990, Cell.

[2]  S. Akira,et al.  Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[4]  M. Krönke,et al.  The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin‐1 signal transduction , 1994, Journal of leukocyte biology.

[5]  S. Snyder,et al.  Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Kawamoto,et al.  1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. , 1984, Biochemical and biophysical research communications.

[7]  A. Nel,et al.  Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. , 1993, Journal of immunology.

[8]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[9]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[10]  P. Jones,et al.  Staurosporine inhibits protein kinases activated by Ca2+ and cyclic AMP in addition to inhibiting protein kinase C in rat islets of Langerhans , 1993, Molecular and Cellular Endocrinology.

[11]  A. Yao,et al.  Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. , 1994, Circulation research.

[12]  A. Saltiel,et al.  Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor(*) , 1995, The Journal of Biological Chemistry.

[13]  E. Hoffman,et al.  Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. , 1994, The Journal of biological chemistry.

[14]  F. Neumann,et al.  Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. , 1995, Circulation.

[15]  S. Akira,et al.  The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. , 1993, The Journal of biological chemistry.

[16]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[17]  M. Montminy,et al.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB , 1988, Nature.

[18]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[19]  T. Tamaoki,et al.  Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. , 1989, Biochemical and biophysical research communications.

[20]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[21]  J. Blenis,et al.  Requirement of serine phosphorylation for formation of STAT-promoter complexes. , 1995, Science.

[22]  A. Yao,et al.  Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. , 1997, The American journal of physiology.

[23]  A. Ray,et al.  Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Pfeilschifter,et al.  Molecular cloning of the rat inducible nitric oxide synthase gene promoter. , 1996, Biochemical and biophysical research communications.

[25]  B. Russell,et al.  The cAMP response element binding protein is expressed and phosphorylated in cardiac myocytes. , 1994, Circulation research.

[26]  C. Chang,et al.  Molecular Cloning and Expression of an Avian Macrophage Nitric-oxide Synthase cDNA and the Analysis of the Genomic 5′-Flanking Region (*) , 1996, The Journal of Biological Chemistry.

[27]  M. Lapointe,et al.  Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes. , 1996, Hypertension.

[28]  T. Taniguchi,et al.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements , 1988, Cell.

[29]  S. Harroch,et al.  Induction by interleukin‐6 of interferon regulatory factor 1 (IRF‐1) gene expression through the palindromic interferon response element pIRE and cell type‐dependent control of IRF‐1 binding to DNA. , 1994, The EMBO journal.

[30]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[31]  T. Taniguchi,et al.  Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. , 1994, Science.

[32]  T. Taniguchi,et al.  Interferon-β gene regulation: Tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer , 1987, Cell.

[33]  M. Entman,et al.  Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. , 1995, Circulation.

[34]  J. Mudgett,et al.  Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Nichols,et al.  Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. , 1992, The EMBO journal.

[36]  P. Tsao,et al.  Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. , 1996, Circulation.

[37]  R. Fallon.  Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes. , 1990, Biochemical and biophysical research communications.

[38]  R. Simmons,et al.  cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. , 1995, The American journal of physiology.

[39]  M. Greenberg,et al.  Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB , 1994, Cell.

[40]  H. Coste,et al.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.

[41]  K. Matsushima,et al.  Establishment of Lipopolysaccharide-dependent Nuclear Factor κB Activation in a Cell-free System (*) , 1995, The Journal of Biological Chemistry.

[42]  C. Nathan,et al.  Role of interferon regulatory factor 1 in induction of nitric oxide synthase , 1994, The Journal of experimental medicine.

[43]  A. DeFranco,et al.  Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. , 1992, The Journal of biological chemistry.

[44]  G. Waeber,et al.  The promoter of the gene encoding 3',5'-cyclic adenosine monophosphate (cAMP) response element binding protein contains cAMP response elements: evidence for positive autoregulation of gene transcription. , 1993, Endocrinology.

[45]  W. Fiers,et al.  Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. Implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor necrosis factor signal transduction pathway. , 1992, The Journal of biological chemistry.

[46]  C. Nathan,et al.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.

[47]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[48]  G. Breithardt,et al.  The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. , 1995, Transplantation.

[49]  M. Yokoyama,et al.  Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. , 1993, The Journal of biological chemistry.

[50]  A. Yao,et al.  Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes. , 1995, The Journal of clinical investigation.

[51]  Ca(2+)-growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells. , 1995, Cardiovascular research.

[52]  K. Matsushima,et al.  Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. , 1994, The Journal of biological chemistry.

[53]  Z. Yang,et al.  Identification and characterization of a bovine lipopolysaccharide‐binding protein , 1994, Journal of leukocyte biology.

[54]  D. Ron,et al.  C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H. Hidaka,et al.  N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[57]  T. Suzuki,et al.  Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). , 1993, The Journal of biological chemistry.

[58]  J. Balligand,et al.  Nitric oxide and cardiac function. , 1996, Circulation research.

[59]  C. Goldring,et al.  In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. , 1996, Nucleic acids research.

[60]  A. C. Webb,et al.  Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene , 1994, Molecular and cellular biology.

[61]  P. Tsao,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1996, Circulation.